DNA
|3 min read
5 Must-Knows for Extracting Protein, DNA, and RNA from a Single Sample
A single sample can reveal a more complete picture of disease across DNA, RNA, and protein
|2 min read
Earlier Use of Metagenomic Sequencing May Streamline Meningitis, Encephalitis Workups
Modeling data suggests early metagenomic sequencing could reduce unnecessary testing and shorten time to diagnosis for CNS infections
|3 min read
DNA Testing of Colorectal Polyps Improves Insight into Hereditary Risks
European collaboration demonstrates the value of targeted tumor analysis
|3 min read
FDA Clears Roche HER2 Tests to Expand Treatment Options in Metastatic Breast Cancer
Roche’s PATHWAY HER2 (4B5) test is the only test approved to identify all levels of HER2 expression
|4 min read
MIT Researchers Find a More Precise Way to Edit the Genome
MIT researchers have dramatically lowered the error rate of prime editing, a technique that holds potential for treating many genetic disorders
|2 min read
Association for Molecular Pathology Publishes Best Practice Recommendations for Clinical HRD Testing
Joint consensus report includes organizational representation from AMP, ASCO, ACCC, and CAP
|3 min read
How Reverse Transcription Works: From RNA to DNA Explained
Reverse transcription has fundamentally reshaped molecular biology by enabling the flow of genetic information from RNA back to DNA
Available on Demand
Optimizing Genetic Health Risk Testing: The Power of Preanalytical Systems
Join Today’s Clinical Lab with experts from Targeted Genomics and DNA Genotek for an in-depth discussion on the role of Genetic Health Risk Tests (GHR) in advancing personalized healthcare, and how integrating sample collection devices validated for their analytical performance can enhance the reliability and accessibility of GHRsSponsored by
|4 min read
Sanger Sequencing for Specific and Small-Scale DNA Testing
Cost, time, and labor considerations still make the Sanger method a better choice amidst new sequencing technologies
|3 min read
Tumor DNA in the Blood Can Predict Lung Cancer Outcome
Researchers have found that a test to detect circulating tumor DNA can predict lung cancer outcome
Updated |2 min read
New England Biolabs Launches EM-seq v2, an Updated Kit for More Sensitive Detection of 5mC and 5hmC
This bisulfite-free method of methylation detection provides a faster, more streamlined workflow that enables highly sensitive analysis
|3 min read
ASH 2024: Study Shows Genetic Mutations Accumulate in Smokers with Myelodysplastic Syndromes and Worsen Outcomes
Study is the first to identify discrete genetic mutations associated with smoking, to establish a dose-response relationship between smoking and genetic mutations and to show that continuing to smoke leads to more mutations and worse MDS
|2 min read
